Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
90y-dota-tyr3-octreotide (1 trial)
dotatate 90y (1 trial)
lutetium dotatate lu-177 (Lutathera) (1 trial)
Neuroendocrine Tumors (Phase 2)
Trials (1 total)
Trial APIs (3 total)